erlotinib Diseases - LARVOL Sigma


Phase N/A 1 2 3 4 Trials	0	35	70	105	140	175	210	245	280	315	350



Carcinoma




Respiratory Tract Neoplasms




Lung Neoplasms




Carcinoma, Non-Small-Cell Lung




Thoracic Neoplasms




Bronchial Neoplasms




Carcinoma, Bronchogenic




Respiratory Tract Diseases




Digestive System Diseases




Gastrointestinal Diseases




Digestive System Neoplasms




Gastrointestinal Neoplasms




Adenocarcinoma




Lung Diseases




Endocrine Gland Neoplasms




Endocrine System Diseases




Neoplasms by Histologic Type




Neoplasms, Glandular and Epithelial




Pancreatic Neoplasms




Head and Neck Neoplasms




Carcinoma, Squamous Cell




Neoplasm Metastasis




Neoplasms, Squamous Cell




Neoplasms, Germ Cell and Embryonal




Disease Progression




Neoplasms, Nerve Tissue




Neuroectodermal Tumors




Neuroepithelioma




Urogenital Neoplasms




Glioblastoma




Neoplasms, Neuroepithelial




Neoplastic Processes




Skin Diseases




Glioma




Colorectal Neoplasms




Intestinal Diseases




Intestinal Neoplasms




Astrocytoma




Rectal Diseases




Sarcoma




Neutropenia




Pancreatic Diseases




Adenocarcinoma of Lung




Brain Neoplasms




Breast Diseases




Breast Neoplasms




Colonic Diseases




Gliosarcoma




Oral Cancer




Laryngeal Cancer



	Diseases Companies Products Productz Mechanisms of Action Sites